European Archives - Page 904 of 1008 - European Medical Journal

EMJ

Organoids: Mini-Organs for Gastrointestinal Research

RESEARCH on the intestine is a rapidly evolving field for a multitude of reasons, not least due to the incredible progress made in the development of…

EMJ

Signature 3: A New Hope for Gastric Cancer Patients

SIGNATURE 3, a specific genomic molecular fingerprint, represents a fresh avenue of investigation for physicians and researchers aiming to…

EMJ

How Giant Cells Dispose of Giant Waste

PHAGOCYTIC multinucleated giant cells (MGCs) act as the waste disposal men of the body by clearing away bulky waste materials that carry the potential…

EMJ

How the Body Stops the Type 2 Immune Response and Onset of Allergic Disease

SUPPRESSION of group 2 innate lymphoid (IL2) cells following infection has been shown to prevent the innate immune response from continuing when…

EMJ

Genome-Wide Meta-Analysis Provides Insight into the ‘Atopic March’

SEVEN genetic risk loci have been identified for the ‘atopic march’, the sequential progression of different allergic conditions frequently seen in…

EMJ

Translating cancer immunotherapy to the clinic

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Sergio Quezada, PhD, from University College London, London, UK, discusses…

EMJ

ESMO Asia 2015 Congress

LUGANO/SINGAPORE, 16 December 2015 – ESMO, the leading professional organisation for medical oncology, is pleased to announce the inaugural ESMO Asia…

EMJ

Latin American Migrants in Spain Should Be Screened for Chagas Disease

Seville, Spain – 5 December 2015: Latin American migrants in Spain should be screened for Chagas disease, particularly women before pregnancy…

EMJ

Can Cancer Itself Damage the Heart?

Seville, Spain – 3 December 2015: Research presented today at EuroEcho-Imaging 2015 raises the possibility that cancer itself may damage heart muscle…

EMJ

New SEER Registry “Big Data” Demonstrates the Oncotype DX® Test Accurately Predicts Clinical Breast Cancer Outcomes, Bringing the Total Number of Patients in Prospective Outcome Studies to 50,000

GENEVA, Switzerland, [December 14, 2015] – Genomic Health today announced results from multiple Oncotype DX® breast cancer test studies at the…